Aarti-Drugs-Ltd Stock/Share Prices, Buy and Sell Aarti-Drugs-Ltd NSE Stocks

Market Snapshot

BSE Sensex: 40938.13 0.88%
BSE 500: 15491.65 0.78%
BSE 200: 5029.01 0.79%
BSE 100: 12116.68 0.81%
BSE Mid-Cap: 14787.26 0.62%
BSE Small-Cap: 13314.17 0.68%
BANKEX: 36480.86 0.96%
BSE IT Sector: 14934.56 1.20%
Nifty 50: 12054.85 0.69%
Nifty 500: 9758.9 0.70%
Nifty 200: 6193.45 0.71%
Nifty 100: 12151.35 0.71%
Nifty Midcap 100: 16884.75 0.68%
Nifty Small 100: 5641.15 0.65%
Nifty IT: 15108.6 0.91%
Nifty PSU Bank: 2544.05 2.95%

News:

Ganges Securities Ltd leads ga...
UCO Bank leads gainers in A gr...
Magma Fincorp hits the roof af...
ITDC jumps on bargain hunting...
Navin Fluorine gains after boa...

Aarti Drugs Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

13 Dec 2019 | 12:49 PM

506.60

0.75 (0.15%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-9.54%

Return (1Y)

Underperformed Nifty 50 by 21.03%
More Volatile

1.57%

Standard Deviation (1Y)

Higher than Nifty 50 by 0.69%
Not so consistent

5/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

707

427

News & Announcements

Aarti Drugs standalone net profit rises 70.83% in the September 2019 quarter
49 days ago

Aarti Drugs standalone net profit rises 70.83% in the September 2019 quarter

24 - Oct - 2019 12:00 AM | 49 days ago

Net profit of Aarti Drugs rose 70.83% to Rs 30.80 crore in the quarter ended September 2019 as against Rs 18.03 crore during the previous quarter ended September 2018. Sales rose 38.56% to Rs 442.71 crore in the quarter ended September 2019 as against Rs 319.51 crore during the previous quarter ended September 2018.
Particulars Quarter Ended
Sep. 2019 Sep. 2018 % Var.
Sales 442.71 319.51 39
OPM % 14.73 14.32 -
PBDT 57.35 36.73 56
PBT 45.80 26.68 72
NP 30.80 18.03 71
Powered by Capital Market - Live News
Aarti Drugs consolidated net profit rises 79.00% in the September 2019 quarter
49 days ago

Aarti Drugs consolidated net profit rises 79.00% in the September 2019 quarter

24 - Oct - 2019 12:00 AM | 49 days ago

Net profit of Aarti Drugs rose 79.00% to Rs 32.31 crore in the quarter ended September 2019 as against Rs 18.05 crore during the previous quarter ended September 2018. Sales rose 37.45% to Rs 477.50 crore in the quarter ended September 2019 as against Rs 347.41 crore during the previous quarter ended September 2018.
Particulars Quarter Ended
Sep. 2019 Sep. 2018 % Var.
Sales 477.50 347.41 37
OPM % 14.30 13.53 -
PBDT 59.95 37.36 60
PBT 47.86 26.73 79
NP 32.31 18.05 79
Powered by Capital Market - Live News
Aarti Drugs gets upgradation in credit ratings
139 days ago

Aarti Drugs gets upgradation in credit ratings

26 - Jul - 2019 12:00 AM | 139 days ago

Aarti Drugs announced that CRISIL has recently reviewed the Credit Rating and upgraded the Long-Term Rating from 'CRISIL A/Positive' to 'CRISIL A+/Stable'
Powered by Capital Market - Live News
Aarti Drugs consolidated net profit declines 3.94% in the June 2019 quarter
139 days ago

Aarti Drugs consolidated net profit declines 3.94% in the June 2019 quarter

26 - Jul - 2019 12:00 AM | 139 days ago

Net profit of Aarti Drugs declined 3.94% to Rs 22.45 crore in the quarter ended June 2019 as against Rs 23.37 crore during the previous quarter ended June 2018. Sales rose 8.32% to Rs 405.43 crore in the quarter ended June 2019 as against Rs 374.29 crore during the previous quarter ended June 2018.
Particulars Quarter Ended
Jun. 2019 Jun. 2018 % Var.
Sales 405.43 374.29 8
OPM % 13.49 14.06 -
PBDT 45.44 44.12 3
PBT 33.63 33.72 0
NP 22.45 23.37 -4
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Aarti Drugs Ltd has increased by 9.3% since past 3 Months
FII shareholding in Aarti Drugs Ltd has decreased by -31.58% since past 1 Year
MF shareholding in Aarti Drugs Ltd has increased by 13.67% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2019	Sep. 2018	% Var.
Sales	442.71	319.51	39
OPM %	14.73	14.32	-
PBDT	57.35	36.73	56
PBT	45.80	26.68	72
NP	30.80	18.03	71

Particulars	Quarter Ended
	Sep. 2019	Sep. 2018	% Var.
Sales	477.50	347.41	37
OPM %	14.30	13.53	-
PBDT	59.95	37.36	60
PBT	47.86	26.73	79
NP	32.31	18.05	79

Particulars	Quarter Ended
	Jun. 2019	Jun. 2018	% Var.
Sales	405.43	374.29	8
OPM %	13.49	14.06	-
PBDT	45.44	44.12	3
PBT	33.63	33.72	0
NP	22.45	23.37	-4

General Notifications

My Notifications

Research Notifications

Aarti Drugs Ltd NSE / BSE Pharmaceuticals, Small Cap

506.60 0.75 (0.15%)

News & Announcements

Price vs Volume

Stock Trivia

Aarti Drugs Ltd NSE / BSE
Pharmaceuticals, Small Cap

506.60

0.75 (0.15%)